BIOMAT Database Logo BIOMAT Database Logo

Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis. 2015

Malene R Jepsen, and Søren Kløverpris, and Jakob H Mikkelsen, and Josefine H Pedersen, and Ernst-Martin Füchtbauer, and Lisbeth S Laursen, and Claus Oxvig
From the Department of Molecular Biology and Genetics, Aarhus University, DK-8000 Aarhus, Denmark.

Mammalian stanniocalcin-2 (STC2) is a secreted polypeptide widely expressed in developing and adult tissues. However, although transgenic expression in mice is known to cause severe dwarfism, and targeted deletion of STC2 causes increased postnatal growth, its precise biological role is still unknown. We found that STC2 potently inhibits the proteolytic activity of the growth-promoting metalloproteinase, pregnancy-associated plasma protein-A (PAPP-A). Proteolytic inhibition requires covalent binding of STC2 to PAPP-A and is mediated by a disulfide bond, which involves Cys-120 of STC2. Binding of STC2 prevents PAPP-A cleavage of insulin-like growth factor-binding protein (IGFBP)-4 and hence release within tissues of bioactive IGF, required for normal growth. Concordantly, we show that STC2 efficiently inhibits PAPP-A-mediated IGF receptor signaling in vitro and that transgenic mice expressing a mutated variant of STC2, STC2(C120A), which is unable to inhibit PAPP-A, grow like wild-type mice. Our work identifies STC2 as a novel proteinase inhibitor and a previously unrecognized extracellular component of the IGF system.

UI MeSH Term Description Entries
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011266 Pregnancy-Associated Plasma Protein-A A product of the PLACENTA, and DECIDUA, secreted into the maternal circulation during PREGNANCY. It has been identified as an IGF binding protein (IGFBP)-4 protease that proteolyzes IGFBP-4 and thus increases IGF bioavailability. It is found also in human FIBROBLASTS, ovarian FOLLICULAR FLUID, and GRANULOSA CELLS. The enzyme is a heterotetramer of about 500-kDa. PAPP-A,IGFBP-4 Metalloproteinase,IGFBP-4 Protease,IGFBP-4-Specific Proteinase,Insulin-Like Growth Factor-Dependent IGF Binding Protein-4 Protease,Insulin-Like-Growth Factor Binding Protein-4 Protease,PAPP-alpha,Pregnancy Associated alpha Plasma Protein,Pregnancy-Associated alpha-Plasma Protein,IGFBP 4 Metalloproteinase,IGFBP 4 Protease,Insulin Like Growth Factor Binding Protein 4 Protease,Insulin Like Growth Factor Dependent IGF Binding Protein 4 Protease,Metalloproteinase, IGFBP-4,PAPP alpha,Pregnancy Associated Plasma Protein A,Protease, IGFBP-4
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D005260 Female Females
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006128 Growth Gradual increase in the number, the size, and the complexity of cells of an individual. Growth generally results in increase in ORGAN WEIGHT; BODY WEIGHT; and BODY HEIGHT.

Related Publications

Malene R Jepsen, and Søren Kløverpris, and Jakob H Mikkelsen, and Josefine H Pedersen, and Ernst-Martin Füchtbauer, and Lisbeth S Laursen, and Claus Oxvig
Novel Modulators of the Growth Hormone - Insulin-Like Growth Factor Axis: Pregnancy-Associated Plasma Protein-A2 and Stanniocalcin-2.
December 2017, Journal of clinical research in pediatric endocrinology,
Malene R Jepsen, and Søren Kløverpris, and Jakob H Mikkelsen, and Josefine H Pedersen, and Ernst-Martin Füchtbauer, and Lisbeth S Laursen, and Claus Oxvig
Insulin-like growth factor-2 antisense oligonucleotides inhibits myopia by expression blocking of retinal insulin-like growth factor-2 in guinea pig.
July 2012, Clinical & experimental ophthalmology,
Malene R Jepsen, and Søren Kløverpris, and Jakob H Mikkelsen, and Josefine H Pedersen, and Ernst-Martin Füchtbauer, and Lisbeth S Laursen, and Claus Oxvig
alpha 2-Macroglobulin: a new component in the insulin-like growth factor/insulin-like growth factor binding protein-1 axis.
November 2001, The Journal of biological chemistry,
Malene R Jepsen, and Søren Kløverpris, and Jakob H Mikkelsen, and Josefine H Pedersen, and Ernst-Martin Füchtbauer, and Lisbeth S Laursen, and Claus Oxvig
The growth hormone-insulin-like growth factor-I axis.
March 1996, Clinical science (London, England : 1979),
Malene R Jepsen, and Søren Kløverpris, and Jakob H Mikkelsen, and Josefine H Pedersen, and Ernst-Martin Füchtbauer, and Lisbeth S Laursen, and Claus Oxvig
Aflatoxin B1 modulates the insulin-like growth factor-2 dependent signaling axis.
April 2010, Toxicology in vitro : an international journal published in association with BIBRA,
Malene R Jepsen, and Søren Kløverpris, and Jakob H Mikkelsen, and Josefine H Pedersen, and Ernst-Martin Füchtbauer, and Lisbeth S Laursen, and Claus Oxvig
Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.
June 2007, American journal of physiology. Endocrinology and metabolism,
Malene R Jepsen, and Søren Kløverpris, and Jakob H Mikkelsen, and Josefine H Pedersen, and Ernst-Martin Füchtbauer, and Lisbeth S Laursen, and Claus Oxvig
Insulin-insulin-like growth factor axis and colon cancer.
January 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Malene R Jepsen, and Søren Kløverpris, and Jakob H Mikkelsen, and Josefine H Pedersen, and Ernst-Martin Füchtbauer, and Lisbeth S Laursen, and Claus Oxvig
Growth hormone, the insulin-like growth factor axis, insulin and cancer risk.
January 2011, Nature reviews. Endocrinology,
Malene R Jepsen, and Søren Kløverpris, and Jakob H Mikkelsen, and Josefine H Pedersen, and Ernst-Martin Füchtbauer, and Lisbeth S Laursen, and Claus Oxvig
Exercise and the growth hormone-insulin-like growth factor axis.
January 2010, Medicine and science in sports and exercise,
Malene R Jepsen, and Søren Kløverpris, and Jakob H Mikkelsen, and Josefine H Pedersen, and Ernst-Martin Füchtbauer, and Lisbeth S Laursen, and Claus Oxvig
Osteoporosis and the growth hormone-insulin-like growth factor axis.
January 2002, Hormone research,
Copied contents to your clipboard!